The rising cost of medication in the United States can be a challenge for many patients with Type 2 diabetes. High out-of-pocket expenses can cause some to forgo treatment, leading to disease complications, hospitalizations and even death.
The rising cost of medication in the United States can be a challenge for many patients with Type 2 diabetes. High out-of-pocket expenses can cause some to forgo treatment, leading to disease complications, hospitalizations and even death.
How do you care for a chronic disease when visiting a doctor in person could be risky or not an option at all due to the COVID-19 pandemic? That’s a concern for many people living with diabetes now.
The Louisiana Public Health Institute (LPHI) and the University of California San Francisco (UCSF) have launched a patient-driven study to analyze how COVID-19-related policies affect individuals and the spread of the disease. The study is made possible through a funding award of $4,979,798 from the Patient-Centered Outcomes Research Institute (PCORI).